Therefore, we speculated that serum HO-1 provides a highly specific marker of alveolitis in patients having an AE, in contrast to serum SP-D, levels of which can be increased due to collagen vascular diseases, congestive heart failure, community-acquired pneumonia, and so on [23–25]. This evidence concerns the gene SFTPD and rheumatic disorder.